Chimeric Kunitz domains and their use

Details for Australian Patent Application No. 2007222621 (hide)

Owner Bayer HealthCare AG

Inventors Sperzel, Michael; Dittmer, Frank; Greven, Simone; Franz, Juergen; Apeler, Heiner; Lenz, Juergen; Oehme, Felix; Harrenga, Axel

Agent Davies Collison Cave

Pub. Number AU-A-2007222621

PCT Pub. Number WO2007/101602

Priority 06004693.5 08.03.06 EP

Filing date 1 March 2007

Wipo publication date 13 September 2007

International Classifications

C12N 15/15 (2006.01) Mutation or genetic engineering - Protease inhibitors, e.g. antithrombin, antitrypsin, hirudin

A61K 38/57 (2006.01) Medicinal preparations containing peptides

C07K 14/81 (2006.01) Peptides having more than 20 amino acids - Protease inhibitors

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

Event Publications

11 September 2008 PCT application entered the National Phase

  PCT publication WO2007/101602 Priority application(s): WO2007/101602

14 May 2009 Assignment before Grant

  Bayer HealthCare AG The application has been assigned to Bayer Schering Pharma Aktiengesellschaft

24 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007222639-Stabilized pesticidal granules

2007222615-Webbing, method and ribbon needle loom for producing the same